$2.33T
Total marketcap
$83.95B
Total volume
BTC 50.09%     ETH 15.33%
Dominance

Advanced Oncotherapy plc AVO.L Stock

1.93 GBP {{ price }} 0.000000% {{change_pct}}%
Exchange
LSE
Market Cap
10.44M GBP
LOW - HIGH [24H]
0.0000 - 0.0000 GBP
VOLUME [24H]
0 GBP
{{ volume }}
P/E Ratio
0
Earnings per share
-0.07 GBP

Advanced Oncotherapy plc Price Chart

Advanced Oncotherapy plc AVO.L Financial and Trading Overview

Advanced Oncotherapy plc stock price 1.93 GBP
Previous Close 3.63 GBP
Open 3.51 GBP
Bid 3.5 GBP x 0
Ask 3.75 GBP x 0
Day's Range 3.51 - 3.51 GBP
52 Week Range 2.3 - 25.75 GBP
Volume 57K GBP
Avg. Volume 1.4M GBP
Market Cap 20.89M GBP
Beta (5Y Monthly) 0.257471
PE Ratio (TTM) N/A
EPS (TTM) -0.07 GBP
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

AVO.L Valuation Measures

Enterprise Value 79.72M GBP
Trailing P/E N/A
Forward P/E -0.0078
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 25.808823
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -3.183

Trading Information

Advanced Oncotherapy plc Stock Price History

Beta (5Y Monthly) 0.257471
52-Week Change -82.41%
S&P500 52-Week Change 20.43%
52 Week High 25.75 GBP
52 Week Low 2.3 GBP
50-Day Moving Average 5.3 GBP
200-Day Moving Average 12.26 GBP

AVO.L Share Statistics

Avg. Volume (3 month) 1.4M GBP
Avg. Daily Volume (10-Days) 1.15M GBP
Shares Outstanding 538.44M
Float 208.29M
Short Ratio N/A
% Held by Insiders 40.25%
% Held by Institutions 25.22%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:25

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2021
Most Recent Quarter (mrq) June 30, 2022
Next Fiscal Year End December 31, 2022

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -11.73%
Return on Equity (ttm) -67.33%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -25048378 GBP
Net Income Avi to Common (ttm) -32604732 GBP
Diluted EPS (ttm) -0.07
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 2.51M GBP
Total Cash Per Share (mrq) 0.005 GBP
Total Debt (mrq) 59.74M GBP
Total Debt/Equity (mrq) 98.71 GBP
Current Ratio (mrq) 1.263
Book Value Per Share (mrq) 0.136

Cash Flow Statement

Operating Cash Flow (ttm) -26650056 GBP
Levered Free Cash Flow (ttm) -34956660 GBP

Profile of Advanced Oncotherapy plc

Country United Kingdom
State N/A
City London
Address 4 Tenterden Street
ZIP W1S 1TE
Phone 44 20 3617 8728
Website https://www.avoplc.com
Industry Medical Devices
Sector(s) Healthcare
Full Time Employees 174

Advanced Oncotherapy plc, together with its subsidiaries, engages in the designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.

Q&A For Advanced Oncotherapy plc Stock

What is a current AVO.L stock price?

Advanced Oncotherapy plc AVO.L stock price today per share is 1.93 GBP.

How to purchase Advanced Oncotherapy plc stock?

You can buy AVO.L shares on the LSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Advanced Oncotherapy plc?

The stock symbol or ticker of Advanced Oncotherapy plc is AVO.L.

Which industry does the Advanced Oncotherapy plc company belong to?

The Advanced Oncotherapy plc industry is Medical Devices.

How many shares does Advanced Oncotherapy plc have in circulation?

The max supply of Advanced Oncotherapy plc shares is 5.43M.

What is Advanced Oncotherapy plc Price to Earnings Ratio (PE Ratio)?

Advanced Oncotherapy plc PE Ratio is now.

What was Advanced Oncotherapy plc earnings per share over the trailing 12 months (TTM)?

Advanced Oncotherapy plc EPS is -0.07 GBP over the trailing 12 months.

Which sector does the Advanced Oncotherapy plc company belong to?

The Advanced Oncotherapy plc sector is Healthcare.

Advanced Oncotherapy plc AVO.L included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
FTSE AIM All-Share Index FTAI 75.51 GBP 966.76 USD
-0.02
1.06M GBP 755.91 GBP 966.76 USD 763.17 GBP 976.05 USD 1.06M GBP